Skip to Content

Omnaris Approval History

FDA Approved: Yes (First approved October 20, 2006)
Brand name: Omnaris
Generic name: ciclesonide
Dosage form: Nasal Spray
Company: Altana Pharma
Treatment for: Allergic Rhinitis

Omnaris (ciclesonide) is an intranasal corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Development History and FDA Approval Process for Omnaris

DateArticle
Oct 20, 2006Approval Omnaris Altana Pharma - Treatment for Allergic Rhinitis
Mar  7, 2006Altana Submitted New Drug Applications For Ciclesonide Nasal Spray in the U.S. and Canada; Major Milestone in Broadening the Ciclesonide Product Platform

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide